What price per share is reported for Gallagher’s HCSG stock award?

The Form 4 reports a transaction price of $20.32 per share for the 1,969 shares of Healthcare Services Group common stock. This figure serves as the reference price used in the filing to value the stock-based award of unvested deferred stock units.

Director at Healthcare Services Group (HCSG) granted 1,969 unvested DSUs

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

HEALTHCARE SERVICES GROUP INC director Thomas Michael Gallagher received an equity award of 1,969 common‑stock-based units. The Form 4 shows an acquisition of 1,969 shares of Common Stock at a reference price of $20.32 per share, all held directly. A footnote explains these represent 1,969 unvested deferred stock units (DSUs), which are typically part of non-cash director compensation rather than an open-market purchase.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Gallagher Thomas Michael

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,969	$20.32	$40K

Holdings After Transaction: Common Stock — 1,969 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Shares granted: 1,969 shares Reference price: $20.32 per share Shares after transaction: 1,969 shares

3 metrics

Shares granted 1,969 shares Grant of Common Stock / unvested DSUs

Reference price $20.32 per share Reported transaction price for award

Shares after transaction 1,969 shares Direct holdings following grant

Key Terms

DSUs, unvested, Grant, award, or other acquisition

3 terms

DSUs financial

"Amount represents 1,969 unvested DSUs"

DSUs, or Deferred Share Units, are a form of long-term pay where employees or directors receive a promise of company shares or cash at a later date instead of immediate salary. Think of them as an IOU for future stock that vests over time and converts into actual shares or cash, so they matter to investors because they can increase the number of outstanding shares (dilution) and reveal how management’s pay is tied to company performance.

unvested financial

"Amount represents 1,969 unvested DSUs"

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Form 4 Insider Transactions: What Each Field Means →

05/28/2026 - 04:39 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gallagher Thomas Michael

(Last)

(First)

(Middle)

3220 TILLMAN DR

SUITE 300

(Street)

BENSALEM

PENNSYLVANIA

19020

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HEALTHCARE SERVICES GROUP INC [ HCSG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/26/2026		A		1,969⁽¹⁾	A	$20.32	1,969	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Amount represents 1,969 unvested DSUs

Remarks:

	Michael Harrity, by Power of Attorney	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did HCSG director Thomas Michael Gallagher report on this Form 4?

Thomas Michael Gallagher reported receiving 1,969 shares of Healthcare Services Group common stock as an equity award. A footnote clarifies these are unvested deferred stock units (DSUs), reflecting stock-based compensation rather than an open-market stock purchase.

How many HCSG shares did Gallagher acquire and how many does he hold after the grant?

Gallagher acquired 1,969 shares of Healthcare Services Group common stock in this Form 4 transaction. The filing lists 1,969 shares owned directly following the transaction, indicating this grant represents his entire reported position from this filing.

What type of securities did HCSG grant to director Gallagher in this filing?

The filing reports a grant of Common Stock, described in the footnote as 1,969 unvested deferred stock units (DSUs). DSUs are stock-based compensation instruments that typically vest over time rather than being immediately unrestricted, tradable shares.

Was Gallagher’s HCSG stock transaction an open-market buy or a compensation award?

The Form 4 characterizes the transaction as a grant, award, or other acquisition, not an open-market purchase. The 1,969 shares are identified as unvested DSUs, indicating a stock-based compensation award rather than a discretionary market trade by the director.